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The influence of resistance training on neuromuscular function in 
middle-aged and older adults: A systematic review and meta-analysis of 
randomised controlled trials. 
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A R T I C L E  I N F O   






A B S T R A C T   
Background: Deterioration of neuromuscular function is a major mechanism of age-related strength loss. Resis-
tance training (RT) improves muscle strength and mass. However, the effects of RT on neuromuscular adapta-
tions in middle-aged and older adults are unclear. 
Methods: Randomised controlled RT interventions (≥2 weeks) involving adults aged ≥50 years were identified. 
Primary outcome measures were voluntary activation (VA), electromyographic (EMG) activity during maximal 
voluntary contraction (MVC), and antagonist coactivation. Data were pooled using a weighted random-effect 
model. Sub-analyses were conducted by muscle or muscle group and health status of participants. Sensitivity 
analysis was based on study quality. P < 0.05 indicated statistical significance. 
Results: Twenty-seven studies were included. An effect was found for VA (standardised mean difference [SMD] 
0.54, 0.01 to 1.07, P = 0.04), This result remained significant following sensitivity analysis involving only studies 
that were low risk of bias. Subgroup analyses showed an effect for plantar flexor VA (SMD 1.13, 0.20 to 2.06, P =
0.02) and VA in healthy participants (SMD 1.04, 0.32 to 1.76, P = 0.004). There was no effect for EMG activity or 
antagonist coactivation of any muscle group (P > 0.05). 
Discussion: Resistance training did not alter EMG activity or antagonist coactivation in older adults. Sensitivity 
analysis resulted in the effect for VA remaining significant, indicating that this finding was not dependent on 
study quality. Studies predominantly involved healthy older adults (78%), limiting the generalisability of these 
findings to clinical cohorts. Future research should determine the effects of RT on neuromuscular function in 
people with sarcopenia and age-related syndromes.   
1. Introduction 
Skeletal muscle strength (SMS) is essential for physical function but 
declines with biological ageing at a rate of 1.5–5% per year after 50 
years of age (Keller and Engelhardt, 2013). Low SMS is associated with 
increased risk of mortality, morbidity (Leong et al., 2015), falling, 
functional impairment (Menant et al., 2017), and higher hospitalisation 
costs (Antunes et al., 2017). The predictive capacity of low SMS for 
adverse outcomes has recently led to its adoption as the primary diag-
nostic criteria for sarcopenia (Cruz-Jentoft et al., 2019). To prevent loss 
in SMS and/or treat sarcopenia, the impact of targeted interventions on 
the underlying mechanisms of age-related SMS decline needs to be 
explored. 
Impaired neural function is proposed as a major contributor to SMS 
loss (Clark, 2019; Carson, 2018), and appears to precede age-related 
reductions in SMS and muscle mass [SMM; (Reid et al., 2014; Piasecki 
et al., 2018)]. Therefore, targeted interventions to promote neuromus-
cular adaptation in older adults may maintain or improve SMS. Resis-
tance training (RT) is a recommended intervention to manage 
sarcopenia (Dent et al., 2018). Neural adaptations in the early stages of 
RT increase SMS (without hypertrophy) in young men (Akima et al., 
1999). It is unclear whether this plasticity of the neuromuscular system 
is retained in older adults. Arnold and Bautmans (2014) showed that in 
six studies (three non-randomised) of older adults performing RT 
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interventions, voluntary activation (VA) was increased in the plantar 
flexors (PF) and knee extensors (KE). Several randomised controlled 
trials (RCTs) have since been published (Aas et al., 2020; Wei and Ng, 
2018; Kobayashi et al., 2014; van Leeuwen et al., 2014; Beijersbergen 
et al., 2017; Hvid et al., 2016; Kobayashi et al., 2016; Toien et al., 2018), 
thus an up to date and robust review of the literature is required. 
New consensus guidelines emphasising low SMS as a major health 
concern in older adults (Cruz-Jentoft et al., 2019), have coincided with a 
shift in the conceptualisation of strength decline to a function of 
neuromuscular, rather than solely musculoskeletal, impairment (Clark, 
2019; Carson, 2018). Accordingly, quantifying the effect of RT on the 
neuromuscular system is important. This systematic review and meta- 
analysis aims to provide an up-to-date evaluation of RCTs investi-
gating the influence of RT on neuromuscular function in middle-aged 
and older adults. 
2. Methods 
This prospectively registered systematic review and meta-analysis 
(PROSPERO: CRD42019157139) adhered to the Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis Protocols 2015 state-
ment (Moher et al., 2015). 
2.1. Objectives 
To assess the influence of RT compared to no exercise or usual care 
on neuromuscular function in middle-aged and older adults, using 
available RCTs. 
2.2. Inclusion and exclusion criteria 
Table 1 summarises study inclusion criteria. Cohorts aged older than 
50 years were selected because considerable losses in SMS (1.5–5% per 
year) and SMM (1–2% per year) occur after 50 years of age (Keller and 
Engelhardt, 2013). Training duration ≥2 weeks was chosen because 
increases in CAR (Knight and Kamen, 2001) and the number of active 
motor units (Patten et al., 2001), occur in older adults after two weeks of 
RT. We excluded; studies involving participants with neurodegenerative 
disorders or acute neurodegenerative impairment, non-RCTs, studies 
comparing older versus younger participants, conference abstracts, 
study protocols, grey literature and studies duplicating data. 
2.3. Search strategy 
PubMed, Medline, CINAHL and Cochrane Review databases were 
searched by EJ, from database inception onwards (final search: 25th 
March 2020). Search terms associated with “sarcopenia”, “RT”, “muscle 
activation” and “RCT” were combined (see Appendix A in Supplemen-
tary File 1). Independent screening of records (EJ and AO) was per-
formed firstly of titles and abstracts, followed by full-text screening of 
the selected papers to confirm eligibility. Hand-searching of reference 
lists of a systematic review (Arnold and Bautmans, 2014) and eligible 
papers was performed to identify additional studies. Consensus on dis-
agreements was met through discussion with a third reviewer if needed. 
2.4. Data extraction 
Studies were exported to reference management software (Endnote, 
Clarivate Analytics, Philadelphia, USA). Data were extracted and 
recorded (Excel, Microsoft, Washington) independently by two authors 
(EJ & AO; agreement confirmed by EJ), including: participant charac-
teristics; intervention characteristics; muscles assessed; and outcome 
measures (as defined above). Two attempts within four weeks were 
made to contact authors by email to request any missing primary 
outcome data. Data were excluded from the meta-analysis if a response 
was not received. Outcomes reported as mean with standard error (SE) 
were converted to mean with standard deviation [SD; (Higgins and 
Deeks, 2011)]: 




To prevent unit-of-analysis error, where studies compared multiple 
eligible RT interventions to a single control group, intervention groups 
were combined to create a single pair-wise comparison, using formulae 
recommended by the Cochrane Collaboration (Higgins et al., 2011): 















Na + Nb − 1  
where a is group one and b is group two. 
Where available, RT as the sole intervention was selected for inclu-
sion if multiple intervention groups were presented (i.e., a RT group was 
preferred over a combined aerobic and RT group from the same study). 
2.5. Quality assessment 
Risk of bias was assessed by two authors independently (EJ and AO) 
using the Cochrane Risk of Bias (RoB2) tool (Sterne et al., 2019). Dis-
agreements were resolved through consensus (EJ and AO). Due to the 
nature of the intervention, studies were not downgraded based on lack 
of participant blinding. We visually assessed funnel plots for publication 
bias. For sensitivity analysis, meta-analyses were re-run to include 
studies with low risk of bias only. 
2.6. Data synthesis 
End of intervention values for primary outcome data were pooled 
using meta-analysis software (RevMan v5.3.5, Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2014). Low and high 
statistical heterogeneity were defined as I2 <30% and >50%, respec-
tively (Higgins and Thompson, 2002). Due to high heterogeneity, a 
weighted random-effects model was used (Borenstein et al., 2010). 
Antagonist coactivation data are presented as mean difference (MD) 
with 95% confidence intervals (95%CI). Standardised mean difference 
Table 1 
Inclusion criteria defined using the population, intervention, comparison, 
outcome, and study type (PICOS).  
PICOS Description 
Population  • Community-dwelling or care institution residents that were:  
o Sarcopenic (defined by authors according to low SMS and/or 
SMM criteria); or  
o Mean age ≥50 years across study groups 
Intervention  • Resistance training, as a sole or combined intervention, ≥2 weeks 
in duration, including:  
o Exercises for whole body or specific muscles  
o Body-weight exercises, free-weights, resistance bands, isokinetic 
machines, or vibration training  
o Any prescribed number of exercise sets, repetitions and 
intensity, or training frequency 
Comparison  • No exercise, usual care 
Outcome  • Primary: EMG activity, VA (% or CAR) and/or antagonist muscle 
co-activation (%) during MVC of the upper or lower limbs  
• Secondary: SMS, safety, attrition, adherence, and cost effectiveness 
Study type  • Peer-reviewed RCTs  
• All languages 
Notes: CAR = central activation ratio; EMG = electromyographic; MVC =
maximal voluntary contraction; RCT = randomised controlled trial; SMM =
skeletal muscle mass; SMS = skeletal muscle strength; VA = voluntary 
activation. 
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(SMD) with 95%CI is presented where units of measurement could not 
be converted (i.e., CAR or percentage for VA, or various standardisations 
of EMG activity). For VA, an overall analysis was performed followed by 
sub-group analyses based on the muscles assessed. Muscle groups were 
defined using the muscle action i.e., KE, PF, knee flexors (KF), dorsi-
flexors (DF). For EMG activity and antagonist coactivation, some au-
thors reported multiple results for different muscles. Therefore, separate 
meta-analyses were performed by muscle or muscle group in the first 
instance to avoid over-representation of studies with multiple results in 
a single analysis. Subgroup analyses were also performed to determine 
the effect of RT on VA and EMG during MVC in healthy and clinical 
cohorts (defined as patient groups or people with age-related syn-
dromes). Absolute r values of 0.2, 0.5 and 0.8 were considered small, 
moderate and large effect sizes, respectively (Coolican, 2017). P < 0.05 
indicated statistical significance. 
3. Results 
3.1. Results of the search 
The database search identified 869 records, including 272 dupli-
cates. After duplicates were removed, 65 of 597 records were accepted 
from screening titles and abstracts. After review of the 65 full-text ar-
ticles, 27 were selected for inclusion, including three publications 
identified from hand searching (Fig. 1). 
Outcome data were provided by the authors of six studies (Bei-
jersbergen et al., 2017; Cristea et al., 2008; Gurjao et al., 2012; LaRoche 
et al., 2008; Simoneau et al., 2006; Simoneau et al., 2007). Four studies 
met inclusion criteria but did not report participant mean age (Brentano 
et al., 2008), or group allocation method (de Boer et al., 2007; Jiang 
et al., 2016; Rice et al., 1993). After attempts to contact the authors 
these data were not provided, and the four studies were excluded. 
Records identified through database 
searching (869): PubMed (n = 523); 












Records identified from reference lists: 
(n = 3)
Total records: (n = 872)
Records after duplicates removed: (n = 597)




Full-text articles assessed: 
(n = 65) Excluded 
(n = 38):
No non-exercise controls 
(n = 1)
Participants <50years or with 
neurological disorder (n =7)
Did not report ≥1 pre-
established outcome measure 
(n = 16)
Non-randomised (n = 6)
Did not report ≥1 pre-
established outcome measure
and non-randomised (n = 2)
Duplicated data (n = 2)
Incomplete reporting of 
methods /participant 
characteristics (n = 4)
Studies included in 
qualitative synthesis: 
(n = 27)
Studies included in 
quantitative synthesis: 
(n = 20)
Fig. 1. Schematic diagram of the literature search.  
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Outcome data were not obtained for six studies due to the data no longer 
being available (Kobayashi et al., 2016; Karavirta et al., 2011; Ochala 
et al., 2005) or lack of response from the authors (Kobayashi et al., 2014; 
Holsgaard-Larsen et al., 2011; Tracy et al., 2004), and were excluded 
from the meta-analysis. One study compared a vibration training 
intervention group to a control group performing progressive RT as part 
of their usual care. This study was excluded from the meta-analysis 
because we considered this control activity to be too similar to the 
intervention activity assessed in the remainder of the included studies 
(Johnson et al., 2010). Antagonist coactivation data for the control 
group could not be obtained for one study (Cristea et al., 2008). Four 
studies had multiple intervention groups (Karavirta et al., 2011; Correa 
et al., 2012; Holviala et al., 2010; Wallerstein et al., 2012), which were 
approached with the following methods. Two studies compared multiple 
RT intervention groups with a single control group. A two-phase RCT 
(Correa et al., 2012) compared a “traditional training” group with a 
control group in phase one. Phase two involved the sub-division of 
“traditional training” into three intervention groups: traditional, power, 
and rapid strength training. For the meta-analysis phase one, prior to the 
subdivision of the intervention group into multiple groups, was included 
(i.e., “traditional training”). Wallerstein et al. (2012) compared two 
intervention groups, “strength training” and “power training”, to a sin-
gle control group. For the meta-analysis, the strength and power training 
groups were combined to create a single pairwise comparison. Two 
studies allocated participants to strength, endurance, combined strength 
and endurance, and control groups (Karavirta et al., 2011; Holviala 
et al., 2010). Strength as the sole intervention and no – exercise control 
groups were selected for inclusion. 
3.2. Participants and included studies 
Table 2 summarises 27 RCTs included in this review. Primary 
outcome data were assessed in 382 intervention and 284 control par-
ticipants (mean 70.6 ± 8.8 years). The larger participant number allo-
cated to intervention groups is partially due to three studies comparing 
multiple intervention groups to a single control group. Six studies 
included participants with age-related SMM loss, frailty, mobility- 
limitations, patients post-primary hip replacement, and patients await-
ing or post- total knee arthroplasty. The remaining 21 studies involved 
apparently healthy older adults. Cohorts were female only (n = 5 
studies), male only (n = 6 studies) or male and female (n = 16 studies). 
Intervention group mean age was >50 and ≤60 years (n = 2 studies), 
>60 and ≤70 years (n = 7 studies), >70 and ≤80 years (n = 16 studies) 
and >80 years (n = 2 studies). Physical activity status ranged between 
sedentary (n = 2 studies) and elite trained (n = 1 study). 
3.3. Intervention characteristics 
Intervention characteristics are reported in Table 2. Training in-
terventions ranged between three (n = 1 study) and 52 weeks (n = 3 
studies); including ≤10 weeks (n = 11 studies), >10 and ≤20 weeks (n 
= 9 studies), >20 and ≤30 weeks (n = 4 studies), or >50 weeks (n = 3 
studies). Training frequency was predominantly two (n = 10 studies) or 
three (n = 11 studies) sessions per week. Alternatively, studies pre-
scribed two gym-based and one home-based session per week (n = 4 
studies), two to three gym-based and two to three home-based sessions 
per week (n = 1 study). One study increased training frequency from 
three to five sessions per week over the trial period. 
Interventions targeted the lower body (n = 15 studies), or whole 
body (n = 12 studies), using resistance machines (n = 17 studies), vi-
bration platforms (n = 3 studies), free weights (n = 1 study), or a 
mixture of resistance machines and free weights, sandbags, or resistance 
bands (n = 6 studies). Interventions involved; one periodised strength 
and sprint program, one Beginning Movement Load protocol where the 
muscle is passive during lengthening, power, or explosive training (n = 5 
studies), and traditional strength training (n = 17 studies). Studies with 
multiple intervention groups included strength training or power 
training (n = 1 study), and heavy load training at a self-selected or pre- 
determined velocity (n = 1 study). In a two-phase study, traditional 
strength training was first performed by the entire intervention cohort, 
followed by their division into three intervention sub-groups (traditional 
strength, rapid strength, and power training) for phase two. Fifteen in-
terventions were supervised, four used a mix of supervised and unsu-
pervised sessions, and eight studies did not report supervision level. 
3.3.1. Training intensity 
Some training protocols used a percentage of a pre-determined 
maximal effort (e.g., percent of 1RM), or the maximal load that a 
participant could lift for a specified number of repetitions (e.g., 15RM 
signifies the maximal load that can be lifted 15 times). Progressive 
training intensities ranged between 30 and 90% 1RM (n = 7 studies), 4- 
20RM (n = 8 studies), 40–75% 3RM (n = 4 studies) or 60–80% 5RM (n =
2 studies). One intervention maintained the same training load 
throughout (30% 1RM). 
Resistance band protocols progressively increased the band resis-
tance throughout the study period (n = 2 studies). Vibration training 
studies used progressively increased (n = 2 studies) or maintained the 
same (n = 1 study) vibration amplitude, frequency, and training volume 
throughout. Explosive maximal (n = 1 study) and explosive high ve-
locity/low load and low velocity/high load protocols (n = 1 study) were 
also reported. 
3.4. Control characteristics 
Control allocations prescribed “no training” or “no intervention” (n 
= 5 studies). Some participants were instructed to maintain their 
habitual activity (n = 14 studies), including one study involving elite 
athletes that maintained their usual run-based training. “Usual care” 
allocations included progressive RT as standard care (n = 1 study), and 
rehabilitation or therapy programmes using no external resistance (n =
2 studies). Four studies did not specify the control activity. 
3.5. Primary outcomes 
3.5.1. VA 
There was a moderate intervention effect (SMD 0.54, 0.01 to 1.07, P 
= 0.04), with high statistical heterogeneity (I2 = 65%), in nine studies 
that reported the effects of RT on agonist VA. Subgroup analysis by 
muscle group showed a large intervention effect for the PF (SMD 1.13, 
0.20 to 2.06, P = 0.02) and no effect for the KE (SMD 0.14, − 0.37 to 
0.65, P = 0.60). I2 values were 72% and 37% for the PF and KE, 
respectively (Fig. 2). Sub-group analysis by health status showed a large 
intervention effect in healthy adults (SMD 1.04, 0.32 to 1.76, P = 0.004) 
and no effect in clinical cohorts (SMD –0.01, − 0.55 to 0.54, P = 0.99). I2 
values were 63% and 33%, respectively (Fig. 3). Studies reported 
agonist VA as CAR (n = 1 study) or percent (n = 8 studies). One study 
involved patients awaiting total knee arthroplasty reported VA for the 
affected and unaffected leg in the intervention and control group (van 
Leeuwen et al., 2014). The affected leg was chosen for analysis. 
3.5.2. EMG activity during MVC 
Analysis based on muscle group was initially performed. There was 
no effect on EMG activity of the vastus lateralis (VL; SMD 0.38, − 0.30 to 
1.06, P = 0.27, I2 = 80%, Fig. 4A), vastus medialis (VM; SMD 0.61, 
− 0.04 to 1.25, P = 0.07, I2 = 74%, Fig. 4B), rectus femoris (RF; SMD 
1.06, − 0.24 to 2.37, P = 0.11, I2 = 84%, Fig. 4C) or biceps femoris (BF; 
SMD 0.52, − 0.04 to 1.08, P = 0.07, I2 = 0%, Fig. 4D). There was no 
effect on the KE (SMD − 0.01, − 0.67 to 0.65, P = 0.98, I2 = 0%, Fig. 4E) 
or PF (SMD 0.14, − 0.43 to 0.71, P = 0.63, I2 = 0%, Fig. 4F), when 
grouped by the authors. Results could not be pooled for the DF due to 
insufficient data. One study reported EMG during MVC in patients 
following hip replacement surgery (Suetta et al., 2004). Removal of this 
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Table 2 
Characteristics of included RCTs.  
Study details Participants Study characteristics Outcome 
Author (year) N Age (yrs) 
± SD 

















M and F; frail I: Supervised lower- 
extremity RT 
C: Not specified 
2 x/week 
10 weeks 
2–4 × 6–12 
reps 
6-12RM 
KE VA (%) 
Beijersbergen 







M and F; non-mobility 
limited 
I: Lower-extremity power 
training 
C: Usual activity 
3 x/week 
10 weeks 











I (TG): 14 
I (PG): 13 
I (RG): 14 
C: 17 
67 ± 5 F; no regular RT for 
≥1 year 
I: Wks 1–6 (Phase 1) 
Lower-extremity strength 
training 
Wks 7–12 (Phase 2) 
Lower-extremity 
traditional (TG), power 
(PG) or rapid strength (RG) 
training 








3–4 × 8–12 
reps 
8-12RM 
KE rmsEMG (μV) 




I: 66 ± 7.9 
C: 71 ± 10 
M; elite sprinters; no 
RT experience 
I: Periodised whole-body 
strength and sprint training 












KE iEMG (μV∙s) 








F; no systemic 
exercise participation 
I: Supervised whole-body 
strength training 
C: Usual activity 
3 x/week 
8 weeks 
3 × 10–12 
reps 
10-12RM 
KE iEMG (μV∙s) 
Holsgaard- 




69.7 ± 3.4 F; physically active; 
no RT participation 
I: Supervised explosive 
lower-extremity strength 
training 
C: No training 
2 x/week 
12 weeks 
4 × 8–20 reps 
50–80% 1RM 
KE, KF rmsEMG 




I: 56 ± 2 
C: 54 ± 9 
M; physically active; 
no systemic 
endurance or RT 
participation 
I: Supervised whole-body 
strength training 
C: Usual activity 
2 x/week 
21 weeks 
2–5 × 5–20 
reps 
40–85% 1RM 
KE iEMG (μV) 








M and F; mobility- 
limited 
I: Supervised whole-body 
power training 
C: Not specified 
2 x/week 
12 weeks 
3 × 8–10 reps 
70–80% 1RM 
KE VA (%) 








M and F; post-total 
knee arthroplasty 
I: Supervised WBV training 




1–3 × 30–60s KE VA (CAR) 








M; untrained I: Supervised whole-body 
strength training 
C: Not specified 
2 x/week 
21 weeks 
2–4 × 5–20 
reps 
40–85% 1RM 
KE, EE iEMG 








M and F; no recent RT 
or high intensity 
exercise participation 
I: Supervised whole-body 
Beginning Movement Load 
training 
C: Usual activity 
3 x/week 
8 weeks 











I (M): 73 
± 5 








explosive strength training 
C: Not specified 
2 x/week 
4 weeks 
3 × 10 reps 
Maximal 
PF rmsEMG (mV) 












I: Explosive lower- 
extremity RT at two 
angular velocities 
C: Usual activity 
3 x/week 
8 weeks 
3 × 8 reps per 
velocity 
45 deg.⋅s− 1 
and 
200 deg.⋅s− 1 
KE, KF Antagonist 
coactivation (%) 








F; ≤2 h moderate 
exercise weekly 
I: Lower-extremity static 
and dynamic WBV training 
C: Usual activity 
[Weeks 1–4: 3; 
Weeks 5–8: 4; 
Weeks 9–10: 5] 
x/week 
10 weeks 




KE, KF rmsEMG (μV) 
(continued on next page) 
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Table 2 (continued ) 
Study details Participants Study characteristics Outcome 
Author (year) N Age (yrs) 
± SD 

















M; physically active; 
no structured training 
participation 
I: Whole-body supervised 
gym- and unsupervised 
home-based strength 
training 
C: Usual activity 




2–3 × 8–10 
reps 
8-10RM 
PF, DF VA (%); 
Antagonist co- 
activation (%) 








M; physically active; 
no structured training 
participation 
I: Whole-body supervised 
gym- and unsupervised 
home-based strength 
training 
C: Usual activity 




2–3 × 8–10 
reps 
8-10RM 
PF, DF VA (%); 
Antagonist co- 
activation (%) 








M and F; sedentary I: Supervised lower- 
extremity strength training 
C: Usual activity 
2 x/week 
24 weeks 
3 × 10 reps 
50–75% 3RM 
PF rmsEMG 








M and F; no RT 
experience 
I: Supervised whole-body 
strength training 
C: Usual activity 
3 x/week 
14 weeks 
1–2 × 10–15 
reps 
45–80% 5RM 
KE, KF rmsEMG (mV∙s); 
Antagonist co- 
activation (%) 








M and F; physically 
active; no RT 
experience 
I: Supervised whole-body 
strength training 
C: No training 
3 x/week 
14 weeks 
1–2 × 10–15 
reps 
45–80% 5RM 
KE, KF VA (CAR); rmsEMG 
(mV∙s); Antagonist 
co-activation (%) 








M and F; moderately 
active 
I: Lower-extremity 
supervised gym- and 
unsupervised home-based 
strength training 
C: Usual activity 





3 × 10 reps 
50–75% 3RM 
Home-based: 
3 × 8 reps 
(resistance 
band) 
PF, DF VA (%) 








M and F; moderately 
active 
I: Lower-extremity 
supervised gym- and 
unsupervised home-based 
strength training 
C: Usual activity 





3 × 10 reps 
50–75% 3RM 
Home-based: 
3 × 8 reps 
(resistance 
band) 
PF, DF rmsEMG/Mmax; 
Antagonist 
coactivation (%) 








M and F; patients 
post-primary hip 
replacement 




C: Standard rehabilitation 
3 x/week 
12 weeks 
3–5 × 8–10 
reps 
8-20RM 
KE rmsEMG (μV) 




I: 75 ± 5 
C:72 ± 3 
M; moderately to 
highly active; no 
systemic RT 
participation 
I: Supervised lower- 
extremity maximal 
concentric velocity strength 
training 
C: No training 
3 x/week 
3 weeks 
4 × 4 reps 
4RM 
PF VA (%) 
Tracy et al. 
(2004) 
I (HLS): 6 
I (HL): 11 
C: 9 
I (HLS): 
69.7 ± 3.7 
I (HL): 
73.1 ± 4.9 
C:74.2 ±
4.9 
M and F; moderately 
active; no RT 
participation 
I: Supervised lower- 
extremity strength training. 
Heavy load (HL) or heavy 
load steady (HLS) training 
C: No training 
3 x/week 
16 weeks 
3 × 10 reps 
80% 1RM 
KE, KF rmsEMG (mV) 
van Leeuwen 







M and F; patients 
awaiting total knee 
arthroplasty; no RT 
experience 
I: Usual care + lower- 
extremity strength training 
C: Usual care 
[2–3 gym-based; 
2–3 home-based] 
x/week 6 weeks 
3–4 × 8–15 
reps 
8-15RM 
KE VA (%) 









63.6 ± 4.0 
I: Power 
64.9 ± 3.9 
C: 63.0 ±
4.0 
M and F; sedentary or 
lightly active 
I: Whole-body strength or 
power training 








1–4 × 4–7 
reps 
30–50% 1RM 
KE rmsEMG (μV) 








M and F; with age- 
related muscle 
atrophy 
I: Supervised lower- 
extremity static WBV 
training 
C: Usual activity 
3 x/week 12 
weeks 






KE VA (%) 
Notes: sample sizes refer to participants involved in primary outcome analysis. CAR = central activation ratio; C = control; DF = dorsiflexors; EE = elbow extensors; EF 
= elbow flexors; EMG = electromyographic; F = females; HL = heavy load; HLS = heavy load steady; iEMG = integrated EMG; I = intervention; KE = knee extensors; 
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KF = knee flexors; M = males; Mmax = maximal M-wave; PF = plantar flexors; PG = power group; RG = rapid group; RM = repetition maximum; RMS = root mean 
square; RT = resistance training; TG = traditional group; VA = voluntary activation; WBV = whole-body vibration. 
a Included in meta-analysis. 
b Phase 1 of the intervention included in the meta-analysis only. 
Fig. 2. Forest plot of nine trials investigating the effect of RT on VA in middle-aged and older adults. Overall effect size and subgroup analyses by muscle group are 
presented. KE = knee extensors; PF = plantar flexors; VA = voluntary activation. 
Fig. 3. Forest plot of nine trials investigating the effect of RT on VA in middle-aged and older adults. Overall effect size and subgroup analyses by health status are 
presented. KE = knee extensors; PF = plantar flexors; VA = voluntary activation. 
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study did not result in a significant effect on EMG activity in the VL, VM, 
or RF (P ≥ 0.21; figures not shown). EMG parameters during MVC were 
reported in 11 studies for a single (n = 3 studies) or multiple (n = 8 
studies) muscle or muscle groups. 
3.5.3. Antagonist coactivation 
Antagonist coactivation was reported in seven RCTs. No overall ef-
fect for RT was found on antagonist coactivation of the KF during knee 
extension (MD -2.28%, − 9.57 to 5.00%, P = 0.54, I2 = 0%, Fig. 5A) or 
DF during plantar flexion (MD 0.31%, − 3.00 to 3.62%, P = 0.85, I2 =
0%, Fig. 5B). Antagonist coactivation results from Simoneau et al. 
(2006) were excluded from this analysis, in favour of data from the same 
participant cohort at the final timepoint in the same study [i.e. to avoid 
“double counting” the data; (Simoneau et al., 2007)]. No clinical cohorts 
were involved in these studies. Therefore, sub-group analysis by health 
status was not performed. Data for two muscle groups (PF and DF) are 
reported in one study (Simoneau et al., 2007). 
3.6. Secondary outcomes 
3.6.1. Muscle strength 
Twenty-five studies reported at least one SMS assessment for inter-
vention and control groups. Eighteen studies reported a significant 
improvement in SMS in the intervention group post-training in all 
assessed muscles. Where a pre- to post-intervention strength increase is 
reported, the mean improvement was between 6 and 85%, 15 and 40%, 
10 and 93%, and 12 and 30% for the KE, KF, PF, and EE, respectively, 




Fig. 4. Forest plots of 11 trials investigating the effect of RT on EMG activation in middle-aged and older adults during MVC, for the A) vastus lateralis [VL]; B) vastus 
medialis [VM]; C) rectus femoris [RF]; D) biceps femoris [BF]; E) knee extensors [KE] combined; and F) plantar flexors [PF] combined. 
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3.6.2. Attrition 
Participant attrition rates of ≤10% (n = 7 studies), >10% and ≤ 20% 
(n = 7 studies), >20% and ≤30% (n = 3 studies) and 32% were reported 
(n = 1 study). No loss of participants was reported in nine studies. 
3.6.3. Adherence 
Adherence to the intervention (defined as; percentage of prescribed 
training completed) was: 100% in two studies; ≥90% and <100% in six 
studies; and 86% in one study. Four studies set a minimum level of 
training adherence (≥80%, ≥83% or 100%) for participant data to be 
included in the analysis. Three studies extended the intervention period 
as necessary, to ensure all prescribed exercise sessions were completed 
by all participants. Participant adherence was not reported in eleven 
studies. 
3.6.4. Safety 
Adverse events (defined as; injury or illness in participants allocated 
to intervention groups occurring in the study period) included incidence 
of muscle or tendon pain or injury (n = 3 studies), incidence of illness 
unrelated to RT (n = 4 studies), and pain or discomfort during the 
interpolated twitch protocol (n = 2 studies). There were no adverse 
events in five studies. The occurrence or lack of adverse events was not 
reported in 16 studies. 
3.6.5. Cost effectiveness 
No studies reported the cost effectiveness of the intervention. 
3.7. Quality assessment 
Based on five areas of potential bias, one trial was at high risk of bias 
overall, 12 had “some concerns”, and the remaining were low risk 
(Fig. 6). There were too few studies in each meta-analysis to allow for 
accurate identification of asymmetry through visual funnel plot 
assessment. 
3.8. Sensitivity analysis 
After removal of studies with high risk of bias and “some concerns” 
the effect of RT on VA remained significant (SMD 0.92, 0.36 to 1.48, P =
0.001, I2 = 2%). The effect of RT on EMG activity for the VL (SMD 0.02, 
− 0.84 to 0.88, P = 0.97, I2 = 80%), VM (SMD 0.21, − 0.95 to 1.38, P =
0.72, I2 = 86%) and RF (SMD 0.49, − 0.89 to 1.87, P = 0.49, I2 = 84%) 
remained non-significant after removal of studies with high risk of bias 
or “some concerns”. Removal of studies with high risk of bias or “some 
concerns” resulted in too few studies to pool for EMG activity of the KE, 
BF or PF. The same sensitivity analysis did not alter the statistical 
outcome of RT on antagonist coactivation of the DF (MD 0.71%, − 2.96 
to 4.38%, P = 0.71, I2 = 0%). No studies were removed from the analysis 
of antagonist coactivation for the KF. 
4. Discussion 
4.1. Summary of results 




Fig. 4. (continued). 
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influence of RT on strength-related neuromuscular function in middle- 
aged and older adults. The findings demonstrate that RT improves VA, 
in particular of the PF and in healthy cohorts. There was no effect of RT 
on EMG activity during MVC, or antagonist coactivation for any assessed 
muscle or muscle group, in middle-aged and older adults. 
4.2. Agonist muscle activation 
There was an effect of RT on VA (Figs. 2 and 3) but not EMG activity 
of the agonist muscles during MVC (Fig. 4). Several mechanisms might 
underpin training-induced neuromuscular adaptations, including: 
expansion of the neuromuscular junction (Deschenes et al., 2015); 
increased motor unit discharge rate (Kamen and Knight, 2004); and 
lowering of the motor unit recruitment threshold (Van Cutsem et al., 
1998). Within the current review, lower intensity training [progressive 
from 20RM; (Correa et al., 2012; Suetta et al., 2004)], shorter inter-
vention periods [≤6 weeks; (Toien et al., 2018; Johnson et al., 2010; 
Correa et al., 2012)] and partially home-based training (Morse et al., 
2007; Morse et al., 2005) had improved agonist muscle activation. 
Considering the low uptake of RT among older adults (Merom et al., 
2012), and the suggestion that short, low intensity, or unsupervised 
training interventions might be more appealing for older adults unfa-
miliar with RT (Fisher et al., 2017), our findings suggest that these 
preferred training modes may elicit improved muscle activation and 
should therefore be considered when prescribing exercise for older 
adults. 
4.3. Antagonist coactivation 
No effect was found on antagonist coactivation (Fig. 5). The desir-
ability of modifying antagonist coactivation in older adults is debated. 
Coordination of agonist- antagonist muscle activity is modulated by 
disynaptic reciprocal inhibition (Hortobágyi and DeVita, 2006). An age- 
related reduction of spinal inhibition might contribute to an increase in 
antagonist coactivity (Hortobágyi and DeVita, 2006), which subse-
quently decreases net force production (Baratta et al., 1988). This is 
because total muscle force is a product of the simultaneous activation of 
opposing muscles (Carolan and Cafarelli, 1992). However, reductions in 
coactivation might be detrimental in older adults because antagonist 
muscles provide joint stability (Baratta et al., 1988), a factor associated 
with recurrent falls (Nevitt et al., 2016). Alternatively, others report no 
relationship between antagonist coactivation and joint stability in older 
adults (Segal et al., 2015). Therefore, more research is needed to 
determine the training effect on antagonist coactivation in older people 
and the importance of this measure. It is notable that antagonist coac-
tivation was seldom reported, and few of the eight recent studies, pub-
lished since the previous review (Arnold and Bautmans, 2014), reported 
this variable. 
4.4. Subgroup analyses 
After sub-analysis by muscle group, an effect remained for VA of the 
PF (Fig. 2). Increases in SMS in the PF ranged 10 to 93% (see Appendix B 
in Supplementary File 2). This is potentially important because 
increased activation and SMS in the PF reduces incidence of falling in 
older people (Cattagni et al., 2018). However, sub-analysis showed no 
effect for VA of the KE despite reports of increased KE SMS in most 
studies (6 to 85%; see Appendix B in Supplementary File 2). It is 
therefore likely that increases in KE SMS are explained by non-neural 
mechanisms. 
It is unclear why a significant effect for VA remained in the PF but not 
KE. Baseline VA was inversely associated with gains in VA following six 
months of RT (Simoneau et al., 2006). Therefore, greater capacity for 
adaptation might exist in participants with lower initial activation, 
which is proposed to be <90% (Hvid et al., 2016). However, baseline 
measures in the intervention groups reporting VA for KE (71 to 90%, or 
0.9 to 0.95 CAR) and for PF (80 to 88%) were not considerably different. 
Therefore, low initial activation might not consistently determine 
adaptation capacity. 
Predominant muscle fibre type of the tested muscle may explain 
neuromuscular adaptation (Deschenes et al., 2015; Deschenes et al., 
2011). Training-related neuromuscular junction adaptation in ageing 
rats occurred in type 2 muscle fibres only (Deschenes et al., 2015; 
Deschenes et al., 2011). Ageing is associated with a relative increase in 
A
B
Fig. 5. Forest plot of six trials investigating the effect of RT on antagonist coactivation (%) in middle-aged and older adults, for the A) knee flexors [KF]; and B) 
dorsiflexors [DF]. 
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the proportion of type 1 muscle fibre content (Kim et al., 2005), which 
might reduce capacity for neuromuscular training adaptations with age. 
Our findings indicated that improvements in PF VA occurred in inter-
vention groups with a mean age between 70 and 80 years (Toien et al., 
2018; Simoneau et al., 2006; Morse et al., 2007; Morse et al., 2005). 
However, 12 weeks of power training increased KE VA in older partic-
ipants (82.3 ± 1.3 years) with mobility limitations (Hvid et al., 2016). 
Therefore, it is unlikely that our findings are explained by muscle fibre 
changes associated with old age. 
Interestingly, the observed improvements in PF VA occurred in rec-
reationally active, apparently healthy participants (Toien et al., 2018; 
Simoneau et al., 2006; Morse et al., 2007; Morse et al., 2005). There was 
no overall effect for KE VA, which was assessed in one physically active, 
healthy participant group (Reeves et al., 2004) and participants with 
frailty (Aas et al., 2020), low SMM (Wei and Ng, 2018), mobility limi-
tations (Hvid et al., 2016), and osteoarthritis (van Leeuwen et al., 2014; 
Johnson et al., 2010). Accordingly, subgroup analysis of VA by health 
status showed a significant effect for healthy groups and no intervention 
effect for clinical cohorts (Fig. 3). Although two studies reported post- 
training improvements in VA in people with total knee arthroplasty 
(not included in the meta-analysis) and mobility limitations (Hvid et al., 
2016; Johnson et al., 2010), initial health and functional status on 
neuromuscular response to training may be an important factor in the 
capacity for neuromuscular adaptation. Alternatively, this result might 
be explained by study quality. No studies involving clinical populations 
included in this review were considered low risk of bias, thus all four 
studies assessing VA in clinical cohorts were removed during sensitivity 
analysis. Conversely, only two of the five studies involving healthy co-
horts were removed during the sensitivity analysis, with three studies 
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Fig. 6. Study quality using the Cochrane Risk of Bias 2 tool.  
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4.5. Future research 
There is a need for high-quality studies assessing the influence of RT 
on muscle activation in sedentary and clinical cohorts, including people 
with sarcopenia. Across 11 European countries, 71% of adults 50 years 
or older were reported to be physically inactive (Linardakis et al., 2013), 
precluding the transfer of the present finding to the majority of older 
adults. “Probable sarcopenia”, or low SMS, was identified in 5.3% of 
adults over 40 years (Dodds et al., 2020). Furthermore, the presence of 
comorbidity almost doubles the risk of probable sarcopenia (Dodds 
et al., 2020). Improving neuromuscular function in middle-aged and 
older adults with sarcopenia or functional decline is important, due to 
the association between SMS and activation (Aas et al., 2020; Toien 
et al., 2018; Watanabe et al., 2018). Interventions which improve 
neuromuscular function might reverse or prevent the onset of sarcope-
nia, contributing to improved health outcomes for older adults. Studies 
in this review predominantly included recreationally active, apparently 
healthy older adults, highlighting the paucity of studies investigating the 
effects of RT on neuromuscular function in sedentary and clinical co-
horts. Future studies should determine the influence of RT on neuro-
muscular function in previously inactive older adults, particularly those 
with sarcopenia and other coexisting diseases. 
The potential for translation of these findings into clinical practice 
should also be considered. This review showed that RT positively in-
fluences VA. Recent publications have highlighted potential clinical 
applications of surface EMG (McManus et al., 2020; Medved et al., 2020; 
Campanini et al., 2020). In rehabilitation settings, potential uses of EMG 
activity assessment include monitoring of exercise training response, 
non-invasive diagnosis of neuromuscular disorders and provision of vi-
sual biofeedback for goal setting during exercise-based rehabilitation 
(McManus et al., 2020; Medved et al., 2020; Campanini et al., 2020). 
The aetiology of age-related SMS decline is multifactorial, as such 
comprehensive assessment and monitoring of the underlying mecha-
nisms of strength loss in clinical practice, including the use of surface 
EMG, could inform targeted interventions for patients. Whilst there are 
potential benefits of widescale adoption of surface EMG techniques into 
clinical practice, this would require careful consideration of factors 
including: guideline development by an expert panel, the equipment 
costs, time costs for training practitioners and performing the mea-
surement, the standardisation of surface EMG measurement protocols, 
and ensuring that standards and competencies of practitioners are up-
held across centres performing the techniques. Therefore, translation of 
neuromuscular function research into clinical settings requires high- 
quality multi-centre trials in patient cohorts to support its use, along-
side an evaluation of acceptability and cost-effectiveness. Finally, to 
demonstrate the clinical utility of surface EMG in the context of this 
review, i.e., to quantify neuromuscular responses to RT in adults >50 
years, it should be shown to have independent and/or complementary 
benefits to existing measures of RT responses, such as strength. 
4.6. Strengths and limitations 
The strengths of this review are that: (a) a comprehensive literature 
search with no language, date or geographical restrictions was con-
ducted; (b) a broad definition of RT was used to represent current 
practice in exercise prescription; and (c) no health conditions other than 
neurological were considered exclusion criteria, in attempt to identify 
participant cohorts that are representative of the general population. 
Despite a comprehensive search strategy and independent study se-
lection by two authors, it cannot be excluded that relevant references 
were overlooked. Some relevant trials were excluded due to unsuc-
cessful attempts to contact the authors. Bias in the review process may 
have been introduced in the subjective appraisal of study quality using 
the RoB2 tool. 
4.7. Comparison with other reviews 
These results are in agreement with a previous systematic review and 
meta-analysis that reported a significant effect for VA of the PF and no 
effect for antagonist coactivation, in older adults (>60 years) following 
RT (Arnold and Bautmans, 2014). Arnold and Bautmans (2014) found 
an effect for the KE (pooled from three non-controlled studies), a finding 
not supported by our results. The exclusion of non-RCTs, and subsequent 
lower bias, in the present review may explain this discrepancy. 
4.8. Implications 
Resistance training interventions of two to six times per week at an 
intensity ranging from 20RM to maximal training, with three to 20 
repetitions and one to seven sets, appear to be well tolerated in older 
adults with high adherence, low attrition, and few safety concerns. 
Resistance training has a moderate – to – large effect on VA of the lower 
limbs in older adults. 
5. Conclusion 
Lower limb VA improved following RT in middle-aged and older 
people, particularly in the PF and in healthy participants, coinciding 
with increased SMS. There was no RT effect on EMG activity during MVC 
or antagonist coactivation. Studies predominantly involved habitually 
active, healthy older people, meaning that the present results are not 
applicable to people with, or most at risk of, sarcopenia. More high 
quality RCTs are needed to elucidate the influence of RT on neuro-
muscular function in adults with diagnosed sarcopenia and other coex-
isting diseases. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.exger.2021.111320. 
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